Related Experiment Video
Updated: May 30, 2026
09:38
Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Association between apolipoprotein E genotypes and Parkinson's disease
T Pulkes1, C Papsing, S Mahasirimongkol
1Division of Neurology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama 6 Road, Bangkok 10400, Thailand. ratpk@mahidol.ac.th
Summary
The first Thai study found a higher frequency of the apolipoprotein E (APOE)-ε2 allele in Parkinson
Area of Science:
- Neuroscience
- Genetics
- Epidemiology
Background:
- Conflicting evidence exists regarding the association between apolipoprotein E (APOE) alleles and Parkinson's disease (PD).
- Recent research suggests APOE's role in α-synuclein-mediated neurodegeneration, a key pathway in PD.
- The genetic link between APOE and PD requires further investigation in diverse populations.
Purpose of the Study:
- To investigate the association between APOE genotypes and sporadic Parkinson's disease (PD) in the Thai population.
- To determine if specific APOE alleles are risk factors for PD in this ethnic group.
- To contribute to clarifying the role of APOE in PD pathogenesis.
Main Methods:
- A case-control study was conducted.
- Genotyping of apolipoprotein E (APOE) alleles was performed.
- Frequencies of APOE genotypes were analyzed in 155 PD patients and 158 controls.
Main Results:
- A significantly higher frequency of the APOE-ε2 allele was observed in Parkinson's disease (PD) patients compared to controls.
- The odds ratio for PD associated with the APOE-ε2 allele was 2.309 (95% CI: 1.111-4.799).
- This finding suggests a potential susceptibility role for APOE-ε2 in PD within the studied Thai population.
Conclusions:
- The APOE-ε2 allele may be associated with an increased risk of developing Parkinson's disease (PD) in the Thai population.
- Genetic association studies require careful interpretation due to potential confounding factors.
- Further research in large, homogeneous populations is needed to confirm the role of APOE genotypes in PD susceptibility.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...